Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the safety and effectiveness of yoga in reducing shortness of breath in people with chronic obstructive pulmonary disease (COPD). Patients in this study must have moderate to severe COPD and be primarily limited by shortness of breath.
| Condition | Intervention | Phase |
|---|---|---|
|
Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Pulmonary Emphysema Chronic Bronchitis |
Behavioral: yoga |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Efficacy of Yoga for Self-Management of Dyspnea in COPD |
| Estimated Enrollment: | 36 |
| Study Start Date: | January 2003 |
| Estimated Study Completion Date: | July 2004 |
Management of dyspnea (shortness of breath) is a major concern for patients with COPD. The efficacy of complementary exercises to manage dyspnea is unknown. Complementary exercises may be more congruent with patients' lifestyles and values than traditional exercise programs and can be adapted to changes in illness severity and disability. Yoga practice is a complementary therapy that people use to manage their dyspnea. The aims of this study are to: 1) develop a safe and feasible yoga program for patients with COPD; 2) test the efficacy of this program; and 3) determine whether physical performance, psychological well being, and health-related quality of life are positively affected by yoga practice.
Patients in this study will be randomized to receive yoga training or usual care for 12 weeks. Patients will be evaluated at study entry, after each session, and immediately after the training program.
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
- Able to commit to a 12-week yoga class in San Francisco, California
- Moderate to severe COPD, clinically stable for at least 1 month prior to study entry
- Forced Expiratory Volume at one minute (FEV1) < 49% predicted after inhaled bronchodilator
- Activities of daily living limited by shortness of breath
- Ability to speak English and sign consent
- Patients receiving supplemental oxygen will be acceptable if their O2 saturation can be maintained at > 85% on < 6 L/min of nasal oxygen
Exclusion criteria:
- Symptomatic illness (e.g., cancer, left heart failure, ischemic heart disease, neuromuscular disease, psychiatric illness)
- Formal pulmonary rehabilitation training within 1 year prior to study entry
Contacts and Locations| United States, California | |
| University of California | |
| San Francisco, California, United States | |
| Principal Investigator: | Virginia Carrieri-Kohlman, RN, DNSc | University of California, San Francisco |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00051792 History of Changes |
| Other Study ID Numbers: | R21 AT001168-01 |
| Study First Received: | January 16, 2003 |
| Last Updated: | August 16, 2006 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Bronchitis Bronchitis, Chronic Chronic Disease Emphysema Pulmonary Emphysema Lung Diseases Respiration Disorders |
Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Bronchial Diseases Respiratory Tract Diseases Respiratory Tract Infections Disease Attributes Pathologic Processes |
ClinicalTrials.gov processed this record on June 17, 2013